{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:55:24Z","timestamp":1789149324379,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22467-4","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:54:43Z","timestamp":1762347283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bifidobacterium bifidum enhances hepatic mitochondrial \u03b2-oxidation and ameliorates MAFLD in a high-fat diet rat model"],"prefix":"10.1038","volume":"15","author":[{"given":"Fatemeh","family":"Dashti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9929-0081","authenticated-orcid":false,"given":"Ava","family":"Bolandparvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-5366","authenticated-orcid":false,"given":"Anahita","family":"Panji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hojatifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3289-7502","authenticated-orcid":false,"given":"Mahdi","family":"Alinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Mehboodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4264","authenticated-orcid":false,"given":"Mohammad Hassan","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Mirshekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-2650","authenticated-orcid":false,"given":"Elham","family":"Nadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"10","key":"22467_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.gastrohep.2022.12.002","volume":"46","author":"I Genua","year":"2023","unstructured":"Genua, I., Iruzubieta, P., Rodr\u00edguez-Duque, J. C., P\u00e9rez, A. & Crespo, J. NAFLD and type 2 diabetes: A practical guide for the joint management. Gastroenterolog\u00eda Y Hepatolog\u00eda. 46(10), 815\u2013825 (2023).","journal-title":"Gastroenterolog\u00eda Y Hepatolog\u00eda"},{"key":"22467_CR2","doi-asserted-by":"publisher","first-page":"111648","DOI":"10.1016\/j.diabres.2024.111648","volume":"210","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. & Henry, L. Epidemiology of NAFLD\u2013focus on diabetes. Diabetes Res. Clin. Pract. 210, 111648 (2024).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"22467_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73(1), 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"issue":"Suppl","key":"22467_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton, C., Upendran, Y., Zheng, M-H. & George, J. MAFLD: how is it different from NAFLD? Clin. Mol. Hepatol. 29(Suppl), S17 (2023).","journal-title":"Clin. Mol. Hepatol."},{"issue":"7","key":"22467_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24(7), 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"22467_CR6","doi-asserted-by":"publisher","first-page":"204201882211455","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone, R. M. et al. MAFLD: A multisystem disease. Therapeutic Adv. Endocrinol. Metabolism. 14, 20420188221145549 (2023).","journal-title":"Therapeutic Adv. Endocrinol. Metabolism"},{"issue":"12","key":"22467_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura, S. et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 40(12), 3018\u20133030 (2020).","journal-title":"Liver Int."},{"issue":"4","key":"22467_CR8","first-page":"763","volume":"11","author":"F Nian","year":"2023","unstructured":"Nian, F. et al. Akkermansia muciniphila and Bifidobacterium bifidum prevent NAFLD by regulating FXR expression and gut microbiota. J. Clin. Translational Hepatol. 11(4), 763 (2023).","journal-title":"J. Clin. Translational Hepatol."},{"issue":"1","key":"22467_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40168-022-01374-0","volume":"10","author":"G Kim","year":"2022","unstructured":"Kim, G. et al. Bifidobacterial carbohydrate\/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity. Microbiome 10(1), 188 (2022).","journal-title":"Microbiome"},{"issue":"1","key":"22467_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4014\/jmb.2210.10046","volume":"33","author":"MS Rahman","year":"2023","unstructured":"Rahman, M. S., Lee, Y., Park, D-S. & Kim, Y-S. Bifidobacterium bifidum DS0908 and Bifidobacterium longum DS0950 Culture-supernatants ameliorate obesity-related characteristics in mice with high-fat diet-induced obesity. J. Microbiol. Biotechnol. 33(1), 96 (2023).","journal-title":"J. Microbiol. Biotechnol."},{"key":"22467_CR11","doi-asserted-by":"publisher","first-page":"155285","DOI":"10.1016\/j.phymed.2023.155285","volume":"124","author":"J Liao","year":"2024","unstructured":"Liao, J. et al. Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway. Phytomedicine 124, 155285 (2024).","journal-title":"Phytomedicine"},{"issue":"3","key":"22467_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","volume":"16","author":"E Piccinin","year":"2019","unstructured":"Piccinin, E., Villani, G. & Moschetta, A. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nat. Reviews Gastroenterol. Hepatol. 16(3), 160\u2013174 (2019).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"1","key":"22467_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2337\/db21-0363","volume":"71","author":"W Sun","year":"2022","unstructured":"Sun, W. et al. Hepatic CPT1A facilitates liver\u2013adipose cross talk via induction of FGF21 in mice. Diabetes 71(1), 31\u201342 (2022).","journal-title":"Diabetes"},{"issue":"3","key":"22467_CR14","first-page":"351","volume":"20","author":"M Kohjima","year":"2007","unstructured":"Kohjima, M. et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 20(3), 351\u2013358 (2007).","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"22467_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.molmed.2011.08.003","volume":"18","author":"S Diano","year":"2012","unstructured":"Diano, S. & Horvath, T. L. Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism. Trends Mol. Med. 18(1), 52\u201358 (2012).","journal-title":"Trends Mol. Med."},{"issue":"2","key":"22467_CR16","doi-asserted-by":"publisher","first-page":"e14461","DOI":"10.1111\/cbdd.14461","volume":"103","author":"L Hao","year":"2024","unstructured":"Hao, L., Li, S., Chen, G. & Hu, X. Regulation of UCP2 in nonalcoholic fatty liver disease: from mechanisms to natural product. Chem. Biol. Drug Des. 103(2), e14461 (2024).","journal-title":"Chem. Biol. Drug Des."},{"key":"22467_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40011-019-01097-7","volume":"90","author":"H Bagheri","year":"2020","unstructured":"Bagheri, H., Yaghmaei, P., Modaresi, M., Sabbaghian, M. & Ebrahim-Habibi, A. Glycyrrhizin improves fatty liver symptoms, increases adiponectin and reduces UCP2 expression in Wistar rats. Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci. 90, 191\u2013197 (2020).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci."},{"issue":"8","key":"22467_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4254\/wjh.v7.i8.1012","volume":"7","author":"V Souza-Mello","year":"2015","unstructured":"Souza-Mello, V. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World J. Hepatol. 7(8), 1012 (2015).","journal-title":"World J. Hepatol."},{"key":"22467_CR19","doi-asserted-by":"publisher","first-page":"135949","DOI":"10.1016\/j.neulet.2021.135949","volume":"756","author":"S Shamsipour","year":"2021","unstructured":"Shamsipour, S., Sharifi, G. & Taghian, F. Impact of interval training with probiotic (L. plantarum\/Bifidobacterium bifidum) on passive avoidance test, chat and BDNF in the hippocampus of rats with Alzheimer\u2019s disease. Neurosci. Lett. 756, 135949 (2021).","journal-title":"Neurosci. Lett."},{"key":"22467_CR20","doi-asserted-by":"publisher","first-page":"828522","DOI":"10.3389\/fnut.2022.828522","volume":"9","author":"I Maric","year":"2022","unstructured":"Maric, I. et al. Sex and species differences in the development of diet-induced obesity and metabolic disturbances in rodents. Front. Nutr. 9, 828522 (2022).","journal-title":"Front. Nutr."},{"key":"22467_CR21","doi-asserted-by":"publisher","first-page":"773340","DOI":"10.3389\/fendo.2021.773340","volume":"12","author":"X Long","year":"2021","unstructured":"Long, X. et al. Bifidobacterium adolescentis alleviates liver steatosis and steatohepatitis by increasing fibroblast growth factor 21 sensitivity. Front. Endocrinol. (Lausanne). 12, 773340 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"22467_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.lfs.2006.03.021","volume":"79","author":"Y Zou","year":"2006","unstructured":"Zou, Y. et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79(11), 1100\u20131107 (2006).","journal-title":"Life Sci."},{"key":"22467_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.biopha.2017.08.098","volume":"95","author":"S Gheibi","year":"2017","unstructured":"Gheibi, S., Kashfi, K. & Ghasemi, A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed. Pharmacother. 95, 605\u2013613 (2017).","journal-title":"Biomed. Pharmacother"},{"issue":"3","key":"22467_CR24","first-page":"50","volume":"2","author":"DV Binh","year":"2013","unstructured":"Binh, D. V., Dung, N. T. K., Thao, L., Nhi, N. & Chi, P. Macro-and microvascular complications of diabetes induced by high-fat diet and low-dose streptozotocin injection in rats model. Int. J. Diabetes Res. 2(3), 50\u201355 (2013).","journal-title":"Int. J. Diabetes Res."},{"key":"22467_CR25","doi-asserted-by":"publisher","first-page":"107144","DOI":"10.1016\/j.vascn.2021.107144","volume":"113","author":"ASD Wickramasinghe","year":"2022","unstructured":"Wickramasinghe, A. S. D., Attanayake, A. P. & Kalansuriya, P. Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model. J. Pharmacol. Toxicol. Methods. 113, 107144 (2022).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"22467_CR26","doi-asserted-by":"publisher","first-page":"110490","DOI":"10.1016\/j.cbi.2023.110490","volume":"378","author":"MH Maleki","year":"2023","unstructured":"Maleki, M. H. et al. Bilirubin improves renal function by reversing the endoplasmic reticulum stress and inflammation in the kidneys of type 2 diabetic rats fed high-fat diet. Chem. Biol. Interact. 378, 110490 (2023).","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"22467_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12950-024-00397-8","volume":"21","author":"MH Maleki","year":"2024","unstructured":"Maleki, M. H. et al. Protective and curative effects of unconjugated bilirubin on gene expression of LOX-1 and iNOS in the heart of rats receiving high-fat diet and low dose streptozotocin: a histomorphometric approach. J. Inflamm. (Lond). 21(1), 26 (2024).","journal-title":"J. Inflamm. (Lond)"},{"key":"22467_CR28","doi-asserted-by":"publisher","first-page":"112013","DOI":"10.1016\/j.intimp.2024.112013","volume":"132","author":"M Hasan Maleki","year":"2024","unstructured":"Hasan Maleki, M. et al. Boosting wound healing in diabetic rats: the role of nicotinamide riboside and resveratrol in UPR modulation and pyroptosis Inhibition. Int. Immunopharmacol. 132, 112013 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"22467_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11033-024-09334-7","volume":"51","author":"Z Noori","year":"2024","unstructured":"Noori, Z. et al. Quercetin declines LPS induced inflammation and augments adiponectin expression in 3T3-L1 differentiated adipocytes SIRT-1 dependently. Mol. Biol. Rep. 51(1), 445 (2024).","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"22467_CR30","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1002\/osp4.752","volume":"10","author":"MH Maleki","year":"2024","unstructured":"Maleki, M. H. et al. The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3-L1 adipocytes: the role of SIRT1 pathways. Obes. Sci. Pract. 10(2), e752 (2024).","journal-title":"Obes. Sci. Pract."},{"issue":"4","key":"22467_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan, J. & Kantharia, N. How to calculate sample size in animal studies? J. Pharmacol. Pharmacotherapeutics. 4(4), 303\u2013306 (2013).","journal-title":"J. Pharmacol. Pharmacotherapeutics"},{"issue":"5","key":"22467_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"WN Arifin","year":"2017","unstructured":"Arifin, W. N. & Zahiruddin, W. M. Sample size calculation in animal studies using resource equation approach. Malaysian J. Med. Sciences: MJMS. 24(5), 101 (2017).","journal-title":"Malaysian J. Med. Sciences: MJMS"},{"issue":"1","key":"22467_CR33","first-page":"57","volume":"26","author":"W Scherle","year":"1970","unstructured":"Scherle, W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26(1), 57\u201360 (1970).","journal-title":"Mikroskopie"},{"issue":"4","key":"22467_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3746\/pnf.2015.20.4.266","volume":"20","author":"A Rafati","year":"2015","unstructured":"Rafati, A. et al. Mitigating effect of resveratrol on the structural changes of mice liver and kidney induced by cadmium; a Stereological study. Prev. Nutr. Food Sci. 20(4), 266 (2015).","journal-title":"Prev. Nutr. Food Sci."},{"issue":"4","key":"22467_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1469-7580.2012.01475.x","volume":"220","author":"R Marcos","year":"2012","unstructured":"Marcos, R., Monteiro, R. A. & Rocha, E. The use of design-based stereology to evaluate volumes and numbers in the liver: a review with practical guidelines. J. Anat. 220(4), 303\u2013317 (2012).","journal-title":"J. Anat."},{"issue":"3","key":"22467_CR36","first-page":"218","volume":"46","author":"H Bordbar","year":"2021","unstructured":"Bordbar, H., Soleymani, F., Nadimi, E., Yahyavi, S-S. & Fazelian-Dehkordi, K. A quantitative study on the protective effects of resveratrol against bisphenol A-induced hepatotoxicity in rats: a Stereological study. Iran. J. Med. Sci. 46(3), 218 (2021).","journal-title":"Iran. J. Med. Sci."},{"issue":"132","key":"22467_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.30699\/jambs.29.132.34","volume":"29","author":"S Ashkani-Esfahani","year":"2021","unstructured":"Ashkani-Esfahani, S. et al. The effect of Melissa officinalis extract on streptozotocin-induced diabetes in rats: a stereological study on pancreatic islets and beta-cells. J. Adv. Med. Biomedical Res. 29(132), 34\u201340 (2021).","journal-title":"J. Adv. Med. Biomedical Res."},{"issue":"4","key":"22467_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.micron.2008.12.006","volume":"40","author":"S Karbalay-Doust","year":"2009","unstructured":"Karbalay-Doust, S. & Noorafshan, A. Stereological study of the effects of nandrolone decanoate on the mouse liver. Micron 40(4), 471\u2013475 (2009).","journal-title":"Micron"},{"key":"22467_CR39","doi-asserted-by":"publisher","first-page":"108137","DOI":"10.1016\/j.exppara.2021.108137","volume":"228","author":"F Modabberi","year":"2021","unstructured":"Modabberi, F. et al. Stereological analysis of liver, spleen and bone of leishmania infantum-experimentally infected hamsters. Exp. Parasitol. 228, 108137 (2021).","journal-title":"Exp. Parasitol."},{"key":"22467_CR40","doi-asserted-by":"publisher","first-page":"101871","DOI":"10.1016\/j.jchemneu.2020.101871","volume":"110","author":"M Namavar","year":"2020","unstructured":"Namavar, M., Ghalavandi, M. & Bahmanpour, S. The effect of glutathione and buserelin on the stereological parameters of the hypothalamus in the cyclophosphamide-treated mice. J. Chem. Neuroanat. 110, 101871 (2020).","journal-title":"J. Chem. Neuroanat."},{"issue":"1","key":"22467_CR41","first-page":"66","volume":"10","author":"CS von Bartheld","year":"2012","unstructured":"von Bartheld, C. S. Distribution of particles in the z-axis of tissue sections: relevance for counting methods. NeuroQuantology: Interdisciplinary J. Neurosci. Quantum Phys. 10(1), 66 (2012).","journal-title":"NeuroQuantology: Interdisciplinary J. Neurosci. Quantum Phys."},{"issue":"4","key":"22467_CR42","first-page":"763","volume":"11","author":"F Nian","year":"2023","unstructured":"Nian, F. et al. Akkermansia muciniphila and Bifidobacterium bifidum prevent NAFLD by regulating FXR expression and gut microbiota. J. Clin. Transl Hepatol. 11(4), 763\u2013776 (2023).","journal-title":"J. Clin. Transl Hepatol."},{"issue":"1","key":"22467_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/biomedicines10010084","volume":"10","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Bifidobacterium bifidum shows more diversified ways of relieving non-alcoholic fatty liver compared with bifidobacterium adolescentis. Biomedicines 10(1), 84 (2021).","journal-title":"Biomedicines"},{"issue":"15","key":"22467_CR44","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.3390\/ijms22158298","volume":"22","author":"HC Monroy-Ramirez","year":"2021","unstructured":"Monroy-Ramirez, H. C. et al. PPARs as metabolic sensors and therapeutic targets in liver diseases. Int. J. Mol. Sci. 22(15), 8298 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"22467_CR45","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1096\/fj.202000678R","volume":"34","author":"M Weber","year":"2020","unstructured":"Weber, M. et al. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. FASEB J. 34(9), 11816\u201311837 (2020).","journal-title":"FASEB J."},{"issue":"5","key":"22467_CR46","doi-asserted-by":"publisher","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","volume":"294","author":"M Stefanovic-Racic","year":"2008","unstructured":"Stefanovic-Racic, M. et al. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiology-Endocrinology Metabolism. 294(5), E969\u2013E77 (2008).","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"issue":"1","key":"22467_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40360-023-00730-6","volume":"25","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Fenofibrate alleviates NAFLD by enhancing the PPAR\u03b1\/PGC-1\u03b1 signaling pathway coupling mitochondrial function. BMC Pharmacol. Toxicol. 25(1), 7 (2024).","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"5","key":"22467_CR48","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1159\/000493651","volume":"49","author":"H Zhong","year":"2018","unstructured":"Zhong, H. et al. Genipin reverses HFD-induced liver damage and inhibits UCP2-mediated pyroptosis in mice. Cell. Physiol. Biochem. 49(5), 1885\u20131897 (2018).","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"22467_CR49","first-page":"882","volume":"38","author":"J Xu","year":"2013","unstructured":"Xu, J. et al. Effect of metformin on the expression of SIRT1 and UCP2 in rat liver of type 2 diabetes mellitus and nonalcoholic fatty liver. Zhong Nan Da Xue Xue Bao Yi Xue ban = J. Cent. South. Univ. Med. Sci. 38(9), 882\u2013887 (2013).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue ban = J. Cent. South. Univ. Med. Sci."},{"issue":"7","key":"22467_CR50","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7), 1509\u20131517 (2009).","journal-title":"Diabetes"},{"issue":"5","key":"22467_CR51","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1210\/en.2015-1944","volume":"157","author":"J Hu","year":"2016","unstructured":"Hu, J. et al. Short-chain fatty acid acetate stimulates adipogenesis and mitochondrial biogenesis via GPR43 in brown adipocytes. Endocrinology 157(5), 1881\u20131894 (2016).","journal-title":"Endocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22467-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22467-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22467-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:07:43Z","timestamp":1762351663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22467-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22467-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Animal Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.AEC.1401.066). All experimental procedures were performed in accordance with the relevant guidelines and regulations of Shiraz University of Medical Sciences, as well as international standards for the care and use of laboratory animals. This study is reported in accordance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments;\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38716"}}